Technical Comparison
NVIDIA Corporation - Common Stock vs Apimeds Pharmaceuticals US, Inc. Common Stock
Real-time financial comparison matrix between NVDA and APUS.
Primary Asset
NVD
NVIDIA Corporation - Common Stock
Market Rank #101Live Price$186.64
Market Capitalization$4.5T
24h Change+2.78%
Circulating Supply24B NVDA
Comparison Asset
APU
Apimeds Pharmaceuticals US, Inc. Common Stock
Market Rank #1005753Live Price$2.71
Market Capitalization$4.1M
24h Change-0.92%
Circulating Supply1.5M APUS
Market Metric Matrix
| Comparison Metric | NVDA Value | APUS Value | Dominant Asset |
|---|---|---|---|
| Market Cap Rank | #101 | #1005753 | NVIDIA Corporation - Common Stock |
| Unit Price Valuation | $186.64 | $2.71 | NVIDIA Corporation - Common Stock |
| Total Liquid Cap | $4.5T | $4.1M | NVIDIA Corporation - Common Stock |
Frequently Asked Questions
Is NVIDIA Corporation - Common Stock bigger than Apimeds Pharmaceuticals US, Inc. Common Stock?
NVIDIA Corporation - Common Stock has a market cap of $4.5T, while Apimeds Pharmaceuticals US, Inc. Common Stock sits at $4.1M. Therefore, NVIDIA Corporation - Common Stock is currently the larger financial asset by market capitalization.
What is the price ratio between NVIDIA Corporation - Common Stock and Apimeds Pharmaceuticals US, Inc. Common Stock?
Currently, 1 NVDA is worth 69.00 APUS.